Chanjuan Shi

Chanjuan Shi is a Professor at Duke University, where her research focuses on gastrointestinal oncology, tumor biology, and cancer immunology. Her recent work has characterized the aggressive behavior of grade 3 well-differentiated neuroendocrine tumors, examined the impact of chemotherapy on the colorectal cancer immune microenvironment, and explored the prognostic significance of serotonin expression in pancreatic neuroendocrine tumors. She has contributed to the World Health Organization classification of digestive system tumors and published extensively on the clinicopathology of gastric neuroendocrine tumors. Shi collaborates with leading cancer centers across the United States, Europe, Asia, and Australia, including Memorial Sloan Kettering Cancer Center, Heidelberg University, and the University of Toronto.